Results 301 to 310 of about 9,312,063 (341)

Time trends incidence of celiac disease in a Spanish population. [PDF]

open access: yesPLoS One
Cabo Del Riego JM   +10 more
europepmc   +1 more source

Targeting the Microbiota Reverses C‐Section‐Induced Effects on Intestinal Permeability, Microbiota Composition, and Amygdala Gene Expression in the Mouse

open access: yesNeurogastroenterology &Motility, EarlyView.
The study investigated the impact of the delivery method on the microbiome in mice, revealing increased intestinal permeability and altered gene expression in Caesarean section (CS)‐born mice compared to vaginal birth (VB) mice. Administration of Bifidobacterium breve or GOS/FOS partially mitigated these effects, suggesting targeted microbiota ...
Ana Paula Ventura Silva   +12 more
wiley   +1 more source

Dietary Intake, Symptom Control and Quality of Life After Dietitian‐Delivered Education on a FODMAP Diet for Irritable Bowel Syndrome: A 7‐Year Follow Up

open access: yesNeurogastroenterology &Motility, EarlyView.
Dietitian‐delivered education on a FODMAP diet in patients with IBS showed overall satisfactory relief of symptoms, self‐empowerment in dealing with periods of greater symptoms, and minimal restriction of FODMAPs at an average 7 years' follow‐up. Only the few who continued restriction of all FODMAPs had poor food‐related quality of life.
Hannah Silva   +4 more
wiley   +1 more source

Evidence for Brain‐To‐Gut and Gut‐To‐Brain Pathways in Primary Care Patients With Disorders of Gut‐Brain Interaction, Inflammatory Bowel Disease and Gastroesophageal Reflux Disease

open access: yesNeurogastroenterology &Motility, EarlyView.
Gut–brain pathways are bidirectional, but one pathway may predominate in certain disorders. The brain‐to‐gut pathway predominates in IBS, FD, and GERD, while a gut‐to‐brain disturbance dominates in overlap IBS/FD. Prior medications and gastroenteritis may indicate gut‐brain disturbances and may lead first to DGBI or GERD and later psychological ...
N. A. Koloski   +4 more
wiley   +1 more source

Celiac Disease and Skin Diseases: A Bidirectional Mendelian Randomization Study. [PDF]

open access: yesClin Cosmet Investig Dermatol
Ge C   +8 more
europepmc   +1 more source

Efficacy and Safety of the Enterosorbent Silicolgel in Irritable Bowel Syndrome, IBS‐D and IBS‐M: A Randomized, Double‐Blind, Placebo‐Controlled, Multi‐Center Trial

open access: yesNeurogastroenterology &Motility, EarlyView.
Current treatments often fall short in managing IBS effectively. Silicolgel, an enterosorbent, reduced IBS and other gastrointestinal symptoms in 90% of IBS patients compared to 20% in those on placebo. Enterosorbents are not currently recommended for IBS; silicolgel is a widely available, affordable option for patients with IBS‐D and IBS‐M.
O. Kuzminska   +3 more
wiley   +1 more source

Does Non‐Idealism Entail Particularism?

open access: yes
Journal of Social Philosophy, EarlyView.
John Lawless
wiley   +1 more source

Epidemiology of Meal‐Related Abdominal Discomfort or Pain in Irritable Bowel Syndrome

open access: yesNeurogastroenterology &Motility, EarlyView.
Seventy‐five percent of patients with Rome IV IBS experienced meal‐related abdominal discomfort or pain ≥ 50% of the time. Females, younger individuals, and those with comorbid functional dyspepsia and higher gastrointestinal symptom‐specific anxiety scores were more likely to report frequent meal‐related abdominal discomfort or pain. Recognizing these
Melanie S. Cuffe   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy